[1]
“DASATINIB-LOADED SOLID LIPID NANOPARTICLES FOR ENHANCED ORAL BIOAVAILABILITY AND CANCER THERAPY”, J. Integr. Sci. Soc. Impact, vol. 2, no. 1, pp. 227–234, Jun. 2026, doi: 10.29121/44bf1e16.